The European Regulatory Strategy for flame retardants - The right direction but still a risk of getting lost.


Journal

Chemosphere
ISSN: 1879-1298
Titre abrégé: Chemosphere
Pays: England
ID NLM: 0320657

Informations de publication

Date de publication:
Jan 2024
Historique:
received: 18 08 2023
revised: 29 10 2023
accepted: 05 11 2023
medline: 6 12 2023
pubmed: 20 11 2023
entrez: 19 11 2023
Statut: ppublish

Résumé

Flame retardants (FRs) are a major group of chemicals used to protect against fast developing fires and comply with fire regulations. Many of them have a negative impact on the environment and human health. Some have been phased out, but the vast majority remain on the market including a substantial number of harmful ones. The European Chemicals Agency (ECHA) presented a strategy to phase out harmful flame retardants, based on a group approach. While this approach will help to finally overcome the loop of banning individual chemicals, which are then replaced by similar ones, which need to be banned again, the proposed strategy also contains several flaws, which may inadvertently weaken the strategy. A stronger grouping system is discussed and proposed, in which additional criteria for the evaluation of FRs as groups are included, e.g., more attention for toxic effects, mobility, recyclability and waste production. This discussion paper is intended to contribute to a sustainable approach as proposed in the European Chemicals Sustainability Strategy. It should also help create a truly circular economy.

Identifiants

pubmed: 37981017
pii: S0045-6535(23)02908-9
doi: 10.1016/j.chemosphere.2023.140638
pii:
doi:

Substances chimiques

Flame Retardants 0
Halogenated Diphenyl Ethers 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

140638

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest This paper has been written with financial contribution to J. de Boer from ROCKWOOL, Hedehusene, Denmark. The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Jacob de Boer (J)

Amsterdam Institute for Life and Environment, Vrije Universiteit, De Boelelaan 1085, 1081HV Amsterdam, the Netherlands. Electronic address: jacob.de.boer@vu.nl.

Stuart Harrad (S)

School of Geography, Earth, and Environmental Sciences, University of Birmingham, Birmingham B15 2TT, United Kingdom.

Martin Sharkey (M)

School of Natural Sciences, University of Galway, University Road, Galway H91 CF50, Ireland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH